2 enrolling by invitation. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Enrolling by invitation 2 |
Follow Perceptual Disorders: new trials by email Literature Review of Perceptual Disorders trials Research Report on Perceptual Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures GLP-1, Placebo - Longevity, Quality of Life | Early Phase 1 | Enrolling by invitation | AgelessRx | 150 | 2024-11-01 | 2025-07-30 |
| Quadratus Lumborum Block for Total Hip Arthroplasty Active Comparator, Placebo Comparator - Pain, Postoperative | Early Phase 1 | Enrolling by invitation | University of California, Los Angeles | 80 | 2022-03-29 | 2026-06-05 |
Agnosia (2) · Inflammation (1) · Pain, Postoperative (1)
Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Pain (1) · Postoperative Complications (1)
Glucagon-Like Peptide 1 (1) · semaglutide (1)
AgelessRx (1) · University of California, Los Angeles (1)
United States (2)
Pamela Chia, MD (1)